Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Apr 1;277(4):e839-e848.
doi: 10.1097/SLA.0000000000005530. Epub 2022 Jul 15.

Defining Global Benchmarks for Laparoscopic Liver Resections: An International Multicenter Study

Brian K P Goh  1 Ho-Seong Han  2 Kuo-Hsin Chen  3 Darren W Chua  1 Chung-Yip Chan  1 Federica Cipriani  4 Davit L Aghayan  5 Asmund A Fretland  5 Jasper Sijberden  6 Mizelle D'Silva  2 Tiing Foong Siow  3 Yutaro Kato  7 Chetana Lim  8 Phan Phuoc Nghia  9 Paulo Herman  10 Marco V Marino  11   12 Vincenzo Mazzaferro  13 Adrian K H Chiow  14 Iswanto Sucandy  15 Arpad Ivanecz  16 Sung Hoon Choi  17 Jae Hoon Lee  18 Mikel Gastaca  19 Marco Vivarelli  20 Felice Giuliante  21 Andrea Ruzzenente  22 Chee-Chien Yong  23 Mengqui Yin  24 Zewei Chen  24 Constantino Fondevila  25   26 Mikhail Efanov  27 Fernando Rotellar  28   29 Gi-Hong Choi  30 Ricardo R Campos  31 Xiaoying Wang  32 Robert P Sutcliffe  33 Johann Pratschke  34 Eric Lai  35 Charing C Chong  36 Mathieu D'Hondt  37 Kazuteru Monden  38 Santiago Lopez-Ben  39 Fabricio F Coelho  10 Thomas Peter Kingham  40 Rong Liu  41 Tran Cong Duy Long  42 Alessandro Ferrero  43 Giovanni B Levi Sandri  44 Mansour Saleh  45 Daniel Cherqui  45 Olivier Scatton  8 Olivier Soubrane  46 Go Wakabayashi  47 Roberto I Troisi  48 Tan-To Cheung  49 Atsushi Sugioka  7 Mohammad Abu Hilal  6   50 David Fuks  46 Bjørn Edwin  5 Luca Aldrighetti  4 International Robotic and Laparoscopic Liver Resection Study Group Investigators
Collaborators, Affiliations
Free article
Multicenter Study

Defining Global Benchmarks for Laparoscopic Liver Resections: An International Multicenter Study

Brian K P Goh et al. Ann Surg. .
Free article

Abstract

Objective: To establish global benchmark outcomes indicators after laparoscopic liver resections (L-LR).

Background: There is limited published data to date on the best achievable outcomes after L-LR.

Methods: This is a post hoc analysis of a multicenter database of 11,983 patients undergoing L-LR in 45 international centers in 4 continents between 2015 and 2020. Three specific procedures: left lateral sectionectomy (LLS), left hepatectomy (LH), and right hepatectomy (RH) were selected to represent the 3 difficulty levels of L-LR. Fifteen outcome indicators were selected to establish benchmark cutoffs.

Results: There were 3519 L-LR (LLS, LH, RH) of which 1258 L-LR (40.6%) cases performed in 34 benchmark expert centers qualified as low-risk benchmark cases. These included 659 LLS (52.4%), 306 LH (24.3%), and 293 RH (23.3%). The benchmark outcomes established for operation time, open conversion rate, blood loss ≥500 mL, blood transfusion rate, postoperative morbidity, major morbidity, and 90-day mortality after LLS, LH, and RH were 209.5, 302, and 426 minutes; 2.1%, 13.4%, and 13.0%; 3.2%, 20%, and 47.1%; 0%, 7.1%, and 10.5%; 11.1%, 20%, and 50%; 0%, 7.1%, and 20%; and 0%, 0%, and 0%, respectively.

Conclusions: This study established the first global benchmark outcomes for L-LR in a large-scale international patient cohort. It provides an up-to-date reference regarding the "best achievable" results for L-LR for which centers adopting L-LR can use as a comparison to enable an objective assessment of performance gaps and learning curves.

PubMed Disclaimer

Conflict of interest statement

B.K.P.G. has received travel grants and honorarium from Johnson and Johnson, Olympus, and Transmedic the local distributor for the Da Vinci Robot. M.V.M. is a consultant for CAVA robotics LLC. J.P. reports a research grant from Intuitive Surgical Deutschland GmbH and personal fees or nonfinancial support from Johnson & Johnson, Medtronic, AFS Medical, Astellas, CHG Meridian, Chiesi, Falk Foundation, La Fource Group, Merck, Neovii, NOGGO, pharma-consult Peterson, and Promedicis. M.S. reports personal fees or other support outside of the submitted work from Merck, Bayer, ERBE, Amgen, Johnson & Johnson, Takeda, Olympus, Medtronic, and Intuitive. A.F. reports receiving speaker fees from Bayer. F.R. reports speaker fees and support outside the submitted work from Integra, Medtronic, Olympus, Corza, Sirtex, and Johnson & Johnson. The remaining authors report no conflicts of interest.

References

    1. Von Eiff W. International benchmarking and best practice management: in search of health care and hospital excellence. Adv Health Care Manag. 2015;17:223–252.
    1. Staiger RD, Schwandt H, Puhan MA, et al. Improving surgical outcomes through benchmarking. Br J Surg. 2019;106:59–64.
    1. Clavien PA, Puhan MA. Measuring and achieving the best possible outcomes in surgery. Br J Surg. 2017;104:1121–1122.
    1. Porter ME. What is the value of health care? N Engl J Med. 2010;363:2477–2481.
    1. Sanchez-Velazquez P, Muller X, Malleo G, et al. Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg. 2019;270:211–218.

Publication types